Altasciences Acquires WCCT Global

March 2, 2021

This acquisition is an integral part of Altasciences’ strategic growth plan to provide a comprehensive, fully integrated early phase drug development solution to address the ever-changing outsourcing challenges of biopharmaceutical companies across the globe. We look forward to working side by side with our new team of clinical experts in California, a team that shares our values for excellence, quality, and customer focus,” explained Chris Perkin, CEO at Altasciences.

WCCT Global was founded in 1998 and has conducted over 600 Phase I studies – an area it specializes in – out of over 1,000 Phase I-IV studies the company has conducted to date.


Read the full article at: https://www.businesswire.com/news/home/20210219005254/en/Altasciences-Acquires-WCCT-Global


Copyright © 2020 · Catawba Research, LLC